Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 9 Aug 2007 |
| Novozymes to acquire the enzyme business of Biocon, India | 18 Jul 2007 |
| Total share capital and number of voting rights | 1 Jun 2007 |
| Group financial statement, first quarter 2007 | 25 Apr 2007 |
| Novozymes terminates patent infringement suit | 17 Apr 2007 |